Albumin-bilirubin score is a prognostic factor in hepatocellular carcinoma treated with transarterial radioembolization: A retrospective cohort study

doi:10.4251/wjgo.120863

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 9

This Article

(5)

(0)

(42)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Sep 15, 2026; 18(9): 120863
Published online Sep 15, 2026. doi: 10.4251/wjgo.120863

Full Size Figure Download Figure

Figure 3 Kaplan-Meier curve of overall survival stratified by albumin-bilirubin score (grade 1 vs grade 2). A: Kaplan-Meier survival curve; B: Number of patients at risk at different time points. Patients with albumin-bilirubin grade 1 had a median overall survival of 25 months [95% confidence interval (CI): 20.2-29.8] compared with 10 months (95%CI: 2.8-17.2) in those with albumin-bilirubin grade 2; hazard ratio = 2.67 (95%CI: 1.2-6), P = 0.017. ALBI: Albumin-bilirubin.

Citation: Suárez-Toribio Á, López-Bueno I, Ampuero-Herrojo J, Cabanillas-Casafranca M, Giráldez-Gallego Á, Sousa-Martín JM, Tirado-Hospital JL, Iglesias-López Á, Nacarino-Mejías V, Ferrer-Ríos MT. Albumin-bilirubin score is a prognostic factor in hepatocellular carcinoma treated with transarterial radioembolization: A retrospective cohort study. World J Gastrointest Oncol 2026; 18(9): 120863
URL: https://www.wjgnet.com/1948-5204/full/v18/i9/120863.htm
DOI: https://dx.doi.org/10.4251/wjgo.120863

Suárez-Toribio Á, López-Bueno I, Ampuero-Herrojo J, Cabanillas-Casafranca M, Giráldez-Gallego Á, Sousa-Martín JM, Tirado-Hospital JL, Iglesias-López Á, Nacarino-Mejías V, Ferrer-Ríos MT. Albumin-bilirubin score is a prognostic factor in hepatocellular carcinoma treated with transarterial radioembolization: A retrospective cohort study. World J Gastrointest Oncol 2026; 18(9): 120863 [DOI: 10.4251/wjgo.120863]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.